title: Conference attendees told ISIS-3 shows equal efficacy, safety differences among thrombolytics.
authors.forename: W A
authors.initials: WA
authors.lastname: Check
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy
chemical_list: D005343:Fibrinolytic Agents; D001241:Aspirin